Intestinal Fatty Acid–binding Protein as a Marker of Necrotizing Enterocolitis Incidence and Severity: a Scoping Review
Journal of Surgical Research · 2024-11 · 303 · 613-627
DOI: 10.1016/j.jss.2024.09.059 ↗Kurz gefasst
Scoping Review in der Zeitschrift Journal of Surgical Research, 2024-11. Verfasst von Lourenço Sbragia und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Surgery, Department of Surgery and Anatomy, Ribeirão Preto Medical School, University of São Paulo, Sao Paulo, Brazil; Center f…. Hauptthemen laut MEDLINE: Enterocolitis, Necrotizing, Fatty Acid-Binding Proteins, Biomarkers. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 113 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, State of Sao Paulo Research Foundation.
Abstract (Originalsprache)
INTRODUCTION: Necrotizing enterocolitis (NEC) is a severe inflammatory disease of the gastrointestinal tract and one of the most common life-threatening emergencies affecting newborns. Intestinal fatty acid-binding protein (I-FABP) has been used as a possible marker of intestinal damage in NEC. We aimed to carry out a scoping review of all publications that explore the role of I-FABP in NEC to inspire new research into the potential utility of I-FABP as a marker of NEC. METHODS: We searched for relevant publications using the keywords "necrotizing enterocolitis," "intestinal fatty acid binding protein," "NEC," and "I-FABP" in the National Library of Medicine (PubMed/MEDLINE), Embase, SCOPUS, and Web of Science. Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews was used for reporting findings. RESULTS: We identified 61 relevant articles, which we divided into clinical (n = 47) and experimental (n = 14) groups. CONCLUSIONS: I-FABP is a promising marker of NEC, especially for NEC stage 2 and 3. Urinary I-FABP follows the same patterns as serum and plasma I-FABP. The definitive roles of I-FABP in early diagnosis of NEC, differential diagnosis in breast feeding, alimentary intolerance, and screening of surgical NEC need clarification and remain a challenge to investigators.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pediatric Surgery, Department of Surgery and Anatomy, Ribeirão Preto Medical School, University of São Paulo, Sao Paulo, Brazil; Center for Regenerative Medicine, Abigail Wexner Research Institute, Nationwid…
- Division of Pediatric Surgery, Department of Surgery and Anatomy, Ribeirão Preto Medical School, University of São Paulo, Sao Paulo, Brazil.
- Center for Regenerative Medicine, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, Ohio, Division of Pediatric Surgery, Department of Surgery, The Ohio State University College of Medicine, C…
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- State of Sao Paulo Research Foundation
Zitieren
APA
Sbragia, L., Gualberto, I. J. N., Xia, J., Gadde, R., Saulsbery, A., Hameedi, S., Mársico Dalto, A. L. F., & Olutoye, O. O. (2024). Intestinal Fatty Acid–binding Protein as a Marker of Necrotizing Enterocolitis Incidence and Severity: a Scoping Review. Journal of Surgical Research, 303, 613-627. https://doi.org/10.1016/j.jss.2024.09.059
Vancouver
Sbragia L, Gualberto IJN, Xia J, Gadde R, Saulsbery A, Hameedi S, et al. Intestinal Fatty Acid–binding Protein as a Marker of Necrotizing Enterocolitis Incidence and Severity: a Scoping Review. Journal of Surgical Research. 2024;303:613-627. doi:10.1016/j.jss.2024.09.059
BibTeX
@article{Sbragia2024,
author = {Sbragia, Lourenço and Gualberto, Igor José Nogueira and Xia, Jason and Gadde, Rahul and Saulsbery, Angela and Hameedi, Sophia and Mársico Dalto, Ana Laura Ferreira and Olutoye, Oluyinka O},
title = {Intestinal Fatty Acid–binding Protein as a Marker of Necrotizing Enterocolitis Incidence and Severity: a Scoping Review},
journal = {Journal of Surgical Research},
year = {2024},
volume = {303},
pages = {613--627},
doi = {10.1016/j.jss.2024.09.059}
}
EUVIMED